Senior insider sale
Chief Commercial Officer at TREVI THERAPEUTICS, INC. — senior position signals high conviction
$548.9K
81.31K shares
What this filing means
SIMON FARRELL plans to sell 81.31K shares of TREVI THERAPEUTICS, INC. valued at approximately $548.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2025ACC: 0001972481-25-000049
Officer· Chief Commercial Officer
Since Feb 2026
81.31K
Shares to sell
$548.9K
Approx. market value
81.31K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Options Exercise
Equity Compensation
2/17/2021
17.50KOptions Exercise
Equity Compensation
9/22/2020
63.81KTotal acquired81.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2021 | Options Exercise Equity Compensation | 17.50K | — |
9/22/2020 | Options Exercise Equity Compensation | 63.81K | — |
| Total | 81.31K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
81.31K
Market value
$548.9K
3/10/2025
Total
Units
81.31K
Value
$548.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/10/2025 | 81.31K | $548.9K | Nasdaq | Planned |
| Total | 81.31K | $548.9K | ||